Modified live BRSV vaccine

MYPI1995001214A0Inactive Publication Date: 1995-11-08ZOETIS W LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1995001214
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
1994-05-08
Filing Date
1995-05-08
Publication Date
1995-11-08
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

THE INVENTION PROVIDES AN IMPROVED BRSV VACCINE COMPOSITION, WHICH ADVANTAGEOUSLY PROVIDES IMMUNITY FROM INFECTION AFTER A SINGLE ADMINISTRATION. THE COMPOSITION COMPRISES A MODIFIED LIVE BRS VIRUS AND AN ADJUVANT, WHICH IN COMBINATION PROVIDE IMMUNITY FROM BRSV INFECTION AFTER A SINGLE ADMINISTRATION, AND ELICIT AN IMMUNE RESPONSE SPECIFIC TO BRSV AND INCLUDING CELL-MEDIATED IMMUNITY AND LOCAL (SECRETORY IGA) IMMUNITY. IN A PREFERRED EMBODIMENT, THE BRS VIRUS IS STRAIN 375, AND THE ADJUVANT COMPRISES AN UNSATURATED TURPIN HYDROCARBON, PREFERABLY SQUALENE OR SQUALANE, AND A POLYOXYPROPYLENE-POLYOXYETHYLENE BLOCK COPOLYMER, MOST PREFERABLY ONE WHERE THE COPOLYMER HAS A POLYOXYPROPYLENE (POP) COMPONENT WITH AN AVERAGE MOLECULAR WEIGHT OF ABOUT 3250 TO 4000 AND THE POLYOXYETHYLENE (POE) COMPONENT COMPRISES ABOUT 10-20OF THE TOTAL MOLECULE. THE ADJUVANT MAY OPTIONALLY INCLUDE A SURFACTANT, PREFERABLY A POLYOXYETHYLENESORBITAN MONOOLEATE.
Need to check novelty before this filing date? Find Prior Art